Luliya XL Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin such as dermatophytosis, tinea corporis, tinea cruris, and tinea pedis. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for effective penetration into the stratum corneum, ensuring targeted action at the site of infection. Luliya XL Cream is typically applied once daily to the affected area and surrounding skin after cleansing and drying, with treatment duration varying depending on the infection type and severity, generally ranging from one to two weeks. It is well tolerated, with minimal local adverse effects such as mild burning, itching, or irritation reported infrequently. Use of Luliya XL Cream is contraindicated in individuals with known hypersensitivity to luliconazole or any cream excipients. Caution is advised when applying to large areas or broken skin. This medication should be used under medical supervision, and patients are advised to complete the full course to prevent recurrence and resistance.